Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
55 hedge funds and large institutions have $94.7M invested in Derma Sciences, Inc. Common Stock (DE) in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 14 closing their positions.
11% less funds holding
Funds holding: 62 → 55 (-7)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
46% less capital invested
Capital invested by funds: $174M → $94.7M (-$79.6M)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $35K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$1.94M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$858K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$463K |
| 4 |
D.E. Shaw & Co
New York
|
+$304K |
| 5 |
BC
Broadfin Capital
New York
|
+$288K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$1.64M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.15M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$1.14M |
| 4 |
RA
Royce & Associates
New York
|
-$1.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.03M |
DSCI Hedge Fund Activity: Q3 2015 in Review
55 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q3 2015, worth a combined $94.7M — down 46% from $174M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of DSCI and 7 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 17 added.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $1.94M. The largest seller was Summit Partners Public Asset Management, cutting an estimated $1.64M.
- 55 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q3 2015, down from 62 in Q2 2015.
- Funds reported $94.7M of Derma Sciences, Inc. Common Stock (DE) stock for Q3 2015, down 46% quarter-over-quarter.
- 7 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q3 2015 and 14 closed out, a net change of -7 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q3 2015 was Ghost Tree Capital, an estimated $1.94M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q3 2015 was Summit Partners Public Asset Management, an estimated $1.64M sold.
Based on aggregated 13F filings for Q3 2015.